Welcome to LookChem.com Sign In|Join Free

CAS

  • or

20651-89-2

Post Buying Request

20651-89-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

20651-89-2 Usage

General Description

3,3,6,6-Tetramethylcyclohexane-1,2-dione, also known as diacetone alcohol, is a chemical compound with the molecular formula C9H18O2. It is a colorless liquid with a sweet, floral odor, and is primarily used as a solvent in coatings, paints, varnishes, and other industrial applications. It is also used as a chemical intermediate in the production of dyes, plastics, and pharmaceuticals. Due to its low toxicity and volatility, it is considered to be a relatively safe solvent compared to other organic solvents. Additionally, it is used as a fragrance ingredient in perfumes and as a flavoring agent in food products.

Check Digit Verification of cas no

The CAS Registry Mumber 20651-89-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,0,6,5 and 1 respectively; the second part has 2 digits, 8 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 20651-89:
(7*2)+(6*0)+(5*6)+(4*5)+(3*1)+(2*8)+(1*9)=92
92 % 10 = 2
So 20651-89-2 is a valid CAS Registry Number.
InChI:InChI=1/C10H16O2/c1-9(2)5-6-10(3,4)8(12)7(9)11/h5-6H2,1-4H3

20651-89-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name 3,3,6,6-tetramethylcyclohexane-1,2-dione

1.2 Other means of identification

Product number -
Other names 3,3,6,6-tetramethyl-cyclohexane-1,2-dione

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:20651-89-2 SDS

20651-89-2Relevant articles and documents

An experimental and computational study on isomerically pure, soluble azaphthalocyanines and their complexes and boron azasubphthalocyanines of a varying number of aza units

Liebold, Martin,Sharikow, Eugen,Seikel, Elisabeth,Trombach, Lukas,Harms, Klaus,Zimcik, Petr,Novakova, Veronika,Tonner, Ralf,Sundermeyer, J?rg

, p. 6586 - 6599 (2018)

Herein, we present a series of isomerically pure, peripherally alkyl substituted, soluble and low aggregating azaphthalocyanines as well as their new, smaller hybrid homologues, azasubphthalocyanines. The focus lies on the effect of the systematically increasing number of aza building blocks [-N] replacing the non-peripheral [-CH] units and their influence on the physical and photophysical properties of these chromophores. The absolute and relative HOMO-LUMO energies of azaphthalocyanines were analyzed using UV-Vis and CV and compared to the density functional theory calculations (B3LYP, TD-DFT). The lowering of the HOMO level is revealed as the determining factor for the trend in the adsorption energies by electronic structure analysis. Crystals of substituted subphthalocyanines, N2-Pc?H2 and N4-[Pc?Zn·H2O], were obtained out of DCM. For the synthesis of the valuable tetramethyltetralin phthalocyanine building block a new highly efficient synthesis involving a nearly quantitative CoII catalyzed aerobic autoxidation step is introduced replacing inefficient KMnO4/pyridine as the oxidant.

SYNTHETIC RETINOIDS FOR USE IN RAR ACTIVATION

-

, (2020/09/27)

The present invention relates to compounds of formula I: in which A1-A7 and R1 to R5 are defined herein, for use in the treatment of a condition or disease which is alleviated by the activation of retinoic acid receptors (RAR). The invention also relates to pharmaceutical compounds comprising such compounds, and related methods of treatment. In an aspect, the invention relates to a method of screening compounds for therapeutic potential in the treatment of a condition or disease which is alleviated by the activation of retinoic acid receptors (RAR). Aspects of the invention relate to novel compounds of formula I in which at least one of A1 to A3 is N or at least one of A4 is CR12 or A5 is CR13 in which R12/R13 is halogen.

Highly efficient separation of actinides from lanthanides by a phenanthroline-derived bis-triazine ligand

Lewis, Frank W.,Harwood, Laurence M.,Hudson, Michael J.,Drew, Michael G. B.,Desreux, Jean F.,Vidick, Geoffrey,Bouslimani, Nouri,Modolo, Giuseppe,Wilden, Andreas,Sypula, Michal,Vu, Trong-Hung,Simonin, Jean-Pierre

supporting information; experimental part, p. 13093 - 13102 (2011/10/05)

The synthesis, lanthanide complexation, and solvent extraction of actinide(III) and lanthanide(III) radiotracers from nitric acid solutions by a phenanthroline-derived quadridentate bis-triazine ligand are described. The ligand separates Am(III) and Cm(II

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 20651-89-2